Bausch Health Companies (BHC) Other financing activities (2009 - 2026)

Bausch Health Companies has disclosed Other financing activities across 17 years of filings, most recently posting -$2.0 million for Q1 2026.

• Other financing activities for Q1 2026 came in at -$2.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $43.0 million (up 386.67% YoY), and the FY2025 annual result was $45.0 million, up 509.09% from the prior year.
• Other financing activities came in at -$2.0 million for Q1 2026 at Bausch Health Companies, down from $54.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $54.0 million in Q4 2025 to a low of -$47.0 million in Q4 2023.
• The 5-year median for Other financing activities is $1.0 million (2022), against an average of $6.6 million.
• Peak annual rise in Other financing activities reached 2800.0% in 2025, while the deepest fall reached 400.0% in 2025.
• Bausch Health Companies' Other financing activities stood at $37.0 million in 2022, then sank by 227.03% to -$47.0 million in 2023, then soared by 95.74% to -$2.0 million in 2024, then surged by 2800.0% to $54.0 million in 2025, then sank by 103.7% to -$2.0 million in 2026.
• The last three Other financing activities figures came in at -$2.0 million (Q1 2026), $54.0 million (Q4 2025), and -$45.0 million (Q3 2025), per Business Quant data.